Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies
University of Washington
University of Washington
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
University of Nebraska
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
University College, London
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)